Award

Drug Development Framework

CARDIFF UNIVERSITY

This public procurement record has 1 release in its history.

Award

19 Jan 2021 at 10:24

Summary of the contracting process

Cardiff University, a leading research institution based in Cardiff, UK, has initiated a tender process for the "Drug Development Framework." This procurement, classified under research laboratory services, is currently in the planning stage, although all associated lots have been cancelled. The university is seeking innovative companies with expertise in drug discovery, specifically those equipped to provide electrophysiology services, in-vivo assays, and drug metabolism services. Potential bidders were required to create an account on In-Tend to access tender documents, which was part of an open procurement method aimed at ensuring transparency and competitiveness.

This tender presents significant opportunities for businesses within the pharmaceutical and biotechnology sectors, especially those that specialise in drug discovery and development. Companies offering research laboratory services, particularly those focused on electrophysiology, in-vivo testing, or drug metabolism studies, would be well-positioned to compete for future contracts. Cardiff University's strong emphasis on innovative solutions and high-quality data presents a chance for suppliers dedicated to enhancing the drug development process, which could be invaluable for companies looking to expand their presence in the health sciences market.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Drug Development Framework

Notice Description

Cardiff University are ranked 2nd nationally for the impact of their research and are among the top five universities in the UK for research excellence. Cardiff University has a thriving and innovative research culture, with research that has real impact and makes a positive difference to the world. As part of this, the University is translating fundamental discoveries in disease processes to develop new medicines to meet unmet clinical needs. Cardiff University is looking for companies with an innovative outlook and recognised expertise in supporting drug-discovery projects from early screening (electrophysiology and in vitro DMPK) to delivering de-risked novel molecules to clinical trials. Successful companies will be committed to the principles of the NC3Rs and will add value to our work by providing high-quality data for informing the drug-discovery pipeline.

Lot Information

Electrophysiology Services

We require providers for electrophysiology services relevant to neuroscience drug development. Currently we require validated ion channel assays for GABAA and NMDA modulators, on an automated electrophysiology platform, with QC and report generation. In the near future, it is likely we will require a range of other ion channel assays, as well as manual patch clamp services. We may also want to purchase ion channel expressing cell lines (under a MTA).

In-vivo assays

We require providers for in-vivo assays, most usually with oral administration. We currently require reliable assays for pro-cognitive and anxiolytic effects. In the future, we may require assays to demonstrate other drug modulated effects, such as, but not limited to, an anti-depressive effect.

In-vitro drug metabolism (ADME-Tox) services

We require providers of in-vitro drug metabolism (ADME-Tox) services as part of our drug development pipeline. This includes, but is not limited to, measures of metabolism, permeability and transporters, physicochemical properties, protein binding and toxicology.

In-vivo pharmacokinetics (PK) and toxicology

We require providers of in-vivo drug metabolism (ADME-Tox) services as part of our drug development pipeline.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-028b65
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/001039-2021
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

73 - Research and development services and related consultancy services


CPV Codes

73111000 - Research laboratory services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
19 Jan 20215 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
19 Jan 20215 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Cancelled
Lots Status
Cancelled
Awards Status
Unsuccessful
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
CARDIFF UNIVERSITY
Additional Buyers

EUROPEAN UNION

Contact Name
Not specified
Contact Email
buyline@cardiff.ac.uk
Contact Phone
+44 2920879648

Buyer Location

Locality
CARDIFF
Postcode
CF24 0DE
Post Town
Cardiff
Country
Wales

Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL52 Cardiff and Vale of Glamorgan
Delivery Location
TLL22 Cardiff and Vale of Glamorgan

Local Authority
Cardiff
Electoral Ward
Adamsdown
Westminster Constituency
Cardiff East

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-028b65-2021-01-19T10:24:02Z",
    "date": "2021-01-19T10:24:02Z",
    "ocid": "ocds-h6vhtk-028b65",
    "description": "Bidders will need to create an account via In-Tend (https://in-tendhost.co.uk/cardiffuniversity/aspx/Home) in order to view the tender documents. (WA Ref:107445)",
    "initiationType": "tender",
    "tender": {
        "id": "CU258",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Drug Development Framework",
        "status": "cancelled",
        "classification": {
            "scheme": "CPV",
            "id": "73111000",
            "description": "Research laboratory services"
        },
        "mainProcurementCategory": "services",
        "description": "Cardiff University are ranked 2nd nationally for the impact of their research and are among the top five universities in the UK for research excellence. Cardiff University has a thriving and innovative research culture, with research that has real impact and makes a positive difference to the world. As part of this, the University is translating fundamental discoveries in disease processes to develop new medicines to meet unmet clinical needs. Cardiff University is looking for companies with an innovative outlook and recognised expertise in supporting drug-discovery projects from early screening (electrophysiology and in vitro DMPK) to delivering de-risked novel molecules to clinical trials. Successful companies will be committed to the principles of the NC3Rs and will add value to our work by providing high-quality data for informing the drug-discovery pipeline.",
        "lots": [
            {
                "id": "1",
                "title": "Electrophysiology Services",
                "description": "We require providers for electrophysiology services relevant to neuroscience drug development. Currently we require validated ion channel assays for GABAA and NMDA modulators, on an automated electrophysiology platform, with QC and report generation. In the near future, it is likely we will require a range of other ion channel assays, as well as manual patch clamp services. We may also want to purchase ion channel expressing cell lines (under a MTA).",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "as per procurement docs",
                            "type": "quality",
                            "description": "100"
                        },
                        {
                            "type": "price",
                            "description": "0"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            },
            {
                "id": "2",
                "title": "In-vivo assays",
                "description": "We require providers for in-vivo assays, most usually with oral administration. We currently require reliable assays for pro-cognitive and anxiolytic effects. In the future, we may require assays to demonstrate other drug modulated effects, such as, but not limited to, an anti-depressive effect.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "as per procurement docs",
                            "type": "quality",
                            "description": "100"
                        },
                        {
                            "type": "price",
                            "description": "0"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            },
            {
                "id": "3",
                "title": "In-vitro drug metabolism (ADME-Tox) services",
                "description": "We require providers of in-vitro drug metabolism (ADME-Tox) services as part of our drug development pipeline. This includes, but is not limited to, measures of metabolism, permeability and transporters, physicochemical properties, protein binding and toxicology.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "as per procurement docs",
                            "type": "quality",
                            "description": "100"
                        },
                        {
                            "type": "price",
                            "description": "0"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            },
            {
                "id": "4",
                "title": "In-vivo pharmacokinetics (PK) and toxicology",
                "description": "We require providers of in-vivo drug metabolism (ADME-Tox) services as part of our drug development pipeline.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "name": "as per procurement docs",
                            "type": "quality",
                            "description": "100"
                        },
                        {
                            "type": "price",
                            "description": "0"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "73111000",
                        "description": "Research laboratory services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKL22"
                    }
                ],
                "relatedLot": "1"
            },
            {
                "id": "2",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "73111000",
                        "description": "Research laboratory services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKL22"
                    }
                ],
                "relatedLot": "2"
            },
            {
                "id": "3",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "73111000",
                        "description": "Research laboratory services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKL22"
                    }
                ],
                "relatedLot": "3"
            },
            {
                "id": "4",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "73111000",
                        "description": "Research laboratory services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKL22"
                    }
                ],
                "relatedLot": "4"
            }
        ],
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "coveredBy": [
            "GPA"
        ]
    },
    "awards": [
        {
            "id": "001039-2021-CU258-1",
            "relatedLots": [
                "1"
            ],
            "title": "Electrophysiology Services",
            "status": "unsuccessful",
            "statusDetails": "discontinued"
        },
        {
            "id": "001039-2021-CU258-2",
            "relatedLots": [
                "2"
            ],
            "title": "In-vivo assays",
            "status": "unsuccessful",
            "statusDetails": "discontinued"
        },
        {
            "id": "001039-2021-CU258-3",
            "relatedLots": [
                "3"
            ],
            "title": "In-vitro drug metabolism (ADME-Tox) services",
            "status": "unsuccessful",
            "statusDetails": "discontinued"
        },
        {
            "id": "001039-2021-CU258-4",
            "relatedLots": [
                "4"
            ],
            "title": "In-vivo pharmacokinetics (PK) and toxicology",
            "status": "unsuccessful",
            "statusDetails": "discontinued"
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-1902",
            "name": "Cardiff University",
            "identifier": {
                "legalName": "Cardiff University"
            },
            "address": {
                "streetAddress": "Procurement Services, McKenzie House, 30-36 Newport Road",
                "locality": "Cardiff",
                "region": "UKL",
                "postalCode": "CF24 0DE",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "telephone": "+44 2920879648",
                "email": "Buyline@cardiff.ac.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "http://www.cardiff.ac.uk/business/why-work-with-us/for-suppliers",
                "buyerProfile": "https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0258",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "09",
                        "description": "Education"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-172",
            "name": "European Union",
            "roles": [
                "funder"
            ]
        },
        {
            "id": "GB-FTS-111",
            "name": "High Court",
            "identifier": {
                "legalName": "High Court"
            },
            "address": {
                "streetAddress": "Royal Courts of Justice, The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "telephone": "+44 2079477501"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "id": "GB-FTS-1902",
        "name": "Cardiff University"
    },
    "planning": {
        "budget": {
            "finance": [
                {
                    "id": "1",
                    "description": "Call-off contracts under this framework may be financed by EU funds",
                    "financingParty": {
                        "name": "European Union",
                        "id": "GB-FTS-172"
                    },
                    "relatedLots": [
                        "1",
                        "2",
                        "3",
                        "4"
                    ]
                }
            ]
        }
    },
    "links": [
        {
            "rel": "prev",
            "href": "https://ted.europa.eu/udl?uri=TED:NOTICE:177464-2020:TEXT:EN:HTML"
        }
    ],
    "language": "en"
}